Rate control in transdermal β-estradiol reservoir membrane systems: The role of membrane and adhesive layer

Pharmaceutical Research

Volumn 15, Issue 8, 1998, Pages 1238-1243

  Altenburger, Ralf ^a   Rohr, Uwe D ^a,b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Estradiol; Ethanol; Ethylene vinyl acetate membrane; Rate control; Reservoir system; Transdermal delivery

Indexed keywords

ADHESIVE AGENT; ALCOHOL; ESTRADIOL; ETHYLENE VINYL ACETATE COPOLYMER;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; MEMBRANE PERMEABILITY; PARTITION COEFFICIENT; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ESTRADIOL; MEMBRANES, ARTIFICIAL;

EID: 0031709656     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011944025262     Document Type: Article

References (25)

1. J. A. Balfour and R. C. Heel. Transdermal estradiol: A review of its pharmacodynamic properties and therapeutic efficacy in the treatment of menopausal complaints. Drugs 40:561-582 (1990).
2. L. R. Laufer, J. L. de Fazio, and J. K. L. Lu. Estrogen replacement therapy by transdermal estradiol administration. Am. J. Obstet. Gynecol. 146:533-539 (1983).
3. W. R. Good, M. S. Powers, P. Campbell, and L. Schenkel. A new transdermal delivery system for 17 β-Estradiol. J. Contr. Rel. 2:89-94 (1985).
4. I. Setnikar, L. C. Rovati, B. Vens-Cappell, and C. Hilgenstock. Bioavailabilty of estradiol from two transdermal patches. Arzneim.-Forsch./Drug Res. 46:307-310 (1995).
5. S. F. Gordon. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Am. J. Obstet. Gynecol 173:998-1004 (1995).
6. U. D. Rohr, C. Nauert, and A. M. Ehrly. Kinetik eines neuen Pflaters zur transdermalen Applikation von 17 β-Estradiol. Zentralbl. Gynakol. 117:531-539 (1995).
7. Y. Le Roux, M. L. Borg, M. Sibille, J. Thebault, A. Renoux, M. J. Douin, F. Djebbar, and M. P. Dain. Bioavailability study of Menorest® a new estrogen transdermal delivery system, compared with a transdermal reservoir system. Clin. Drug Invest. 10:172-178 (1995).
8. U. D. Rohr, R. Altenburger, and T. Kissel. Kinetics of the transdermal reservoir membrane system delivering β-estradiol: In vitro/ in vivo correlation. Pharm. Res. 15:875-884 (1998).
9. P. S. Campbell and S. K. Chandrasekaran. US Patent 4379454.
10. R. W. Baker and J. Heller. Materials selections for transdermal delivery systems. In: J. Hadgraft and R. H. Guy (Eds.). Transdermal drug delivery. Marcel Dekker, New York, 1989, pp. 293-311.
11. R. D. Smith, D. E. Robinson, B. Delignieres, B. D. Albertson, T. P. Tomai, M. J. Zinaman, and J. A. Simon. Effects of vehicle supplementation on total estradiol absorption from a transdermal estradiol delivery system. Fertil. Steril. 56:1029-1033 (1991).
12. P. Liu, T. Kurihara-Bergstrom, and W. R. Good. Cotransport of estradiol and ethanol through human skin in vitro: Understanding the permeant/enhancer flux relationship. Pharm. Res. 8:938-944 (1991).
13. A. H. Ghanem, H. Mahmoud, W. I. Higuchi, U. D. Rohr, S. Borsadia, P. Liu, J. L. Fox, and W. R. Good. The effects of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin II: A new quantitative approach. J. Contr. Rel. 6:75-83 (1987).
14. N. A. Megrab, A. C. Williams, and B. W. Barry. Oestradiol permeation across human skin, silastic and snake skin membranes: The effects of ethanol/water co-solvent systems. Int. J. Pharm. 116:101-112 (1995).
15. D. D. Kim, J. L. Kim, and Y. W. Chien. Mutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acid. J. Pharm. Sci. 85:1191-1195 (1996).
16. G. S. Chen, D. D. Kim, and Y. W. Chien. Dual-controlled transdermal delivery of levonorgestrel and estradiol: Enhanced permeation and modulated delivery. J. Contr. Rel. 34:129-143 (1994).
17. T. Kurihara-Bergstrom, K. Knutson, L. J. DeNoble, and C. Y. Goates. Percutaneous absorption enhancement of am ionic molecule by ethanol-water systems in human skin. Pharm. Res. 7:762-766 (1990).
18. S. I. Yum, E. S. Lee, L. Taskovich, and F. Theeuwes. Mechanism of action of ethanol as flux enhancer for drug permeation through human skin. Proc. Int. Symp. Control. Rel. Bioactive Mater. 14:103-104 (1987).
19. R. M. Gale and R. G. Berggen. US Patent 4615699 (1986).
20. R. M. Gale, E. S. Lee, L. T. Taskovich, and S. I. Yum. US Patent 4588580 (1986).
21. T. Higuchi. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11:85-97 (1960).
22. B. Berner, J. H. Otte, G. C. Mazzenga, R. J. Steffens, and C. D. Ebert. Ethanol:water mutually enhanced transdermal therapeutic system I: Nitroglycerin solution properties and membrane transport. J. Pharm. Sci. 78:314-318 (1989).
23. L. K. Pershing, G. E. Parry, and L. D. Lambert. Disparity of in vitro and in vivo oleic acid-enhanced β-estradiol percutaneous absorption across human skin. Pharm. Res. 10:1745-1750 (1993).
24. L. K. Pershing, L. D. Lambert, and K. Knutson. Mechanism of ethanol-enhanced permeation across human skin in vivo. Pharm. Res. 7:170-175 (1990).
25. P. Liu, WQ. I. Higuchi, A. H. Ghanem, J. L. Fox, T. Kurihara-Bergstrom, and W. R. Good. Influence of ethanol on diffusion/ metabolism of β-estradiol in hairless mouse skin for the "asymmetric" situation. Proc. Int. Symp. Control. Rel. Bioactive Mater. 16:35-36 (1989).